Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Integrated Sciences Inc (NQ: NVOS )

2.094 +0.044 (+2.17%)
Streaming Delayed Price Updated: 11:27 AM EDT, May 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,380
Open 2.050
Bid (Size) 1.980 (2)
Ask (Size) 2.100 (4)
Prev. Close 2.050
Today's Range 2.000 - 2.094
52wk Range 1.020 - 3.320
Shares Outstanding 29,913,092
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of... 
Via PRUnderground
Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
Bellevue, WA, United States - 04-26-2022 - 
Via PR Distribution

Performance

YTD
+44.44%
+44.44%
1 Month
-4.80%
-4.80%
3 Month
+59.88%
+59.88%
6 Month
+30.09%
+30.09%
1 Year
-4.37%
-4.37%

More News

Read More
Novo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Multidisciplinary Nasdaq Listed Healthcare Provider Growing via Multiple High Value Acquisitions: Novo Integrated Sciences, Inc. (NASDAQ: NVOS)
Via Viz Release
Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Completes Acquisition of Clinical Consultants International LLC
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Signs Memorandum of Understanding with Boditech Med, a Global Point-of-Care Testing Leader, to Market and Distribute in North America
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ PRO-DIP® Issued U.S. Patent for Oral Pouch Delivery System Technology
From Novo Integrated Sciences, Inc.
Via Business Wire
63 Biggest Movers From Yesterday
Via Benzinga
Novo Integrated Sciences Enters into Purchase Agreement to Acquire Clinical Consultants International LLC
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest
From Novo Integrated Sciences, Inc. Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ IoNovo for Kids Pure Iodine Oral Spray Granted Natural Product Number (NPN) by Health Canada
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Novo Integrated Sciences Reports First Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Reports Fiscal Full Year 2021 Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Acquires Majority Stake in Terragenx
Via Benzinga
Novo Integrated Sciences Acquires Majority Stake in Terragenx and Intellectual Property for FDA and Health Canada Approved Water-Soluble Iodine Micro-Nutrient
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Novo Integrated Sciences (NASDAQ: NVOS) Just Announced a Partnership That Could Shake Up the Telehealth Sector
Via Benzinga
Novo Integrated Sciences’ subsidiary, Novo Healthnet Limited, and EK-Tech Solutions Announce Joint Venture for Enhanced Telehealth Platform
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Signs LOIs to Acquire 7 Pharmacies in the US
Via Benzinga
Multidisciplinary Nasdaq Listed Healthcare Provider Growing via Multiple High Value Acquisitions: Novo Integrated Sciences, Inc. (NASDAQ: NVOS)
Via Get News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.